Finance

Lists
002393:SHE
Tianjin Lisheng Pharmaceutical Co Ltd
CNÂ¥14.14
-1.12%
(-0.16) 1D
Sep 9, 3:04:09 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002393...
Open
CNÂ¥14.28
High
CNÂ¥14.28
Low
CNÂ¥14.09
Mkt. cap
4.31B
Avg. vol.
3.04M
Volume
1.64M
Dividend
5.30%
Quarterly dividend
CNÂ¥0.19
Ex-dividend date
Apr 28, 2026
P/E ratio
28.97
52-wk high
CNÂ¥20.55
52-wk low
CNÂ¥13.37
EPS
CNÂ¥0.49
Shares outstanding
308.29M
No. of employees
2K
Open
CNÂ¥14.28
High
CNÂ¥14.28
Low
CNÂ¥14.09
Mkt. cap
4.31B
Avg. vol.
3.04M
Volume
1.64M
Dividend
5.30%
Quarterly dividend
CNÂ¥0.19
Ex-dividend date
Apr 28, 2026
P/E ratio
28.97
52-wk high
CNÂ¥20.55
52-wk low
CNÂ¥13.37
EPS
CNÂ¥0.49
Shares outstanding
308.29M
No. of employees
2K
About Tianjin Lisheng Pharmaceutical Co Ltd
CEO-
Employees1.6K
Founded1951
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
275.77M
384.73M
332.28M
309.35M
Cost of goods sold
107.04M
220.06M
148.48M
153.50M
Cost of revenue
107.04M
220.06M
148.48M
153.50M
Research and development expenses
31.35M
22.62M
19.98M
19.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
92.87M
135.01M
108.37M
109.40M
Operating expense
127.11M
165.03M
132.42M
134.21M
Total operating expenses
234.15M
385.09M
280.90M
287.72M
Operating income
41.62M
-356.56K
51.38M
21.63M
Other non operating income
-13.24M
13.61M
-7.05K
-353.00K
EBT including unusual items
31.57M
22.59M
62.31M
32.70M
EBT excluding unusual items
34.06M
20.55M
61.02M
30.55M
Income tax expense
2.62M
-25.85M
9.24M
5.69M
Effective tax rate
8.30%
-114.43%
14.83%
17.41%
Other operating expenses
3.04M
7.49M
4.08M
5.42M
Net income
27.82M
45.54M
51.88M
26.44M
Net profit margin
10.09%
11.84%
15.61%
8.55%
Earnings per share
-
-
-
-
Interest and investment income
6.29M
7.66M
10.11M
9.61M
Interest expense
-626.76K
-342.54K
-456.05K
-360.99K
Net interest expenses
5.67M
7.31M
9.65M
9.25M
Depreciation and amortization charges
-
-
-
-
EBITDA
60.86M
18.04M
69.77M
39.25M
Gain or loss from assets sale
-2.24M
-249.61K
-
-
AI content may include mistakes. Learn more
Google apps